Martin R. Dix
Administrative / Regulatory Law
Administrative / Regulatory Law
Create an account to contact this attorney
Are you this attorney? Claim or manage this listing by signing in or creating an attorney account.
Board Certified by The Florida Bar in Health Law, Martin Dix focuses his practice primarily on pharmacy and drug distribution law. His clients encompass nearly all aspects of the legal drug delivery system, including pharmacies, pharmacists, and pharmacy benefit managers; drug wholesalers; drug and dietary supplement manufacturers; retail medical oxygen dealers; and compressed medical gases wholesalers. He has also represented a variety of other health care providers and entities, such as physician practices, health care clinics, clinical laboratories, mental health centers, home health agencies and hospitals.Clients rely on Martin for counsel on pharmacy and healthcare-related licensing, regulatory, HIPAA, Medicaid and Medicare, contract and reimbursement issues.With a comprehensive understanding of the state and federal regulatory agencies, Martin represents clients before the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Florida Board of Pharmacy, Agency for Health Care Administration, Florida Department of Health, Department of Business and Professional Regulation Division of Drugs, Devices and Cosmetics, Office for Civil Rights, Medicaid, Centers for Medicare and Medicaid Services, Agency for Persons with Disabilities, Florida Disabilities Council, Florida Attorney General’s Office, Division of Administrative Hearings, Florida Governor and Cabinet, and other state and federal agencies.Martin is an active member of Akerman’s Cannabis Practice, which provides counsel to clients on the complex legal and business issues impacting companies with interests in the medical and adult-use cannabis industries. He has represented medical marijuana dispensiries and treatment providers on a myriad regulatory issues. Board Certified by The Florida Bar in Health Law, Martin Dix focuses his practice primarily on pharmacy and drug distribution law. His clients encompass nearly all aspects of the legal drug delivery system, including pharmacies, pharmacists, and pharmacy benefit managers; drug wholesalers; drug and dietary supplement manufacturers; retail medical oxygen dealers; and compressed medical gases wholesalers. He has also represented a variety of other health care providers and entities, such as physician practices, health care clinics, clinical laboratories, mental health centers, home health agencies and hospitals.Clients rely on Martin for counsel on pharmacy and healthcare-related licensing, regulatory, HIPAA, Medicaid and Medicare, contract and reimbursement issues.With a comprehensive understanding of the state and federal regulatory agencies, Martin represents clients before the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Florida Board of Pharmacy, Agency for Health Care Administration, Florida Department of Health, Department of Business and Professional Regulation Division of Drugs, Devices and Cosmetics, Office for Civil Rights, Medicaid, Centers for Medicare and Medicaid Services, Agency for Persons with Disabilities, Florida Disabilities Council, Florida Attorney General’s Office, Division of Administrative Hearings, Florida Governor and Cabinet, and other state and federal agencies.Martin is an active member of Akerman’s Cannabis Practice, which provides counsel to clients on the complex legal and business issues impacting companies with interests in the medical and adult-use cannabis industries. He has represented medical marijuana dispensiries and treatment providers on a myriad regulatory issues. Board Certified by The Florida Bar in Health Law, Martin Dix focuses his practice primarily on pharmacy and drug distribution law. His clients encompass nearly all aspects of the legal drug delivery system, including pharmacies, pharmacists, and pharmacy benefit managers; drug wholesalers; drug and dietary supplement manufacturers; retail medical oxygen dealers; and compressed medical gases wholesalers. He has also represented a variety of other health care providers and entities, such as physician practices, health care clinics, clinical laboratories, mental health centers, home health agencies and hospitals. Clients rely on Martin for counsel on pharmacy and healthcare-related licensing, regulatory, HIPAA, Medicaid and Medicare, contract and reimbursement issues. With a comprehensive understanding of the state and federal regulatory agencies, Martin represents clients before the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Florida Board of Pharmacy, Agency for Health Care Administration, Florida Department of Health, Department of Business and Professional Regulation Division of Drugs, Devices and Cosmetics, Office for Civil Rights, Medicaid, Centers for Medicare and Medicaid Services, Agency for Persons with Disabilities, Florida Disabilities Council, Florida Attorney General’s Office, Division of Administrative Hearings, Florida Governor and Cabinet, and other state and federal agencies. Martin is an active member of Akerman’s Cannabis Practice, which provides counsel to clients on the complex legal and business issues impacting companies with interests in the medical and adult-use cannabis industries. He has represented medical marijuana dispensiries and treatment providers on a myriad regulatory issues.
Jurisdiction
Florida
State Capital
Tallahassee
Highest Court
Florida Supreme Court
Bar Association
The Florida Bar
Typical Consultation
$150-$300
Typical Hourly Range
$250-$450/hr
Fee Model Notes
Hourly or flat-fee billing is common.
Estimates vary by market, complexity, urgency, and attorney experience.
Recognized in Best Lawyers since 2013
Nancy Harris
Martin Dix was exceptionally knowledgeable in handling my pharmacy distribution compliance case. His 40 years of experience and board certification in health law were evident in his strategic approach. While his expertise in FDA regulations was impressive, I wish his response time to emails could be a bit quicker. Overall, his deep understanding of drug distribution laws made the process much smoother. Highly recommended for complex regulatory matters.